Early influenza virus characterisation and vaccine effectiveness in England in autumn 2025, a period dominated by influenza A(H3N2) subclade K

Influenza A(H3N2) subclade K (J.2.4.1) has dominated the 2025/26 season start in England. Post-infection ferret antisera raised against northern hemisphere 2025/26 vaccine strains showed reduced reactivity to subclade K viruses in England, aligning with World Health Organization reports. Nevertheless, early post-vaccination, vaccine effectiveness against influenza-related emergency department attendances and hospital admissions remained within typical ranges, at 72-75% in children and adolescents (< 18 years) and 32-39% in adults. Hence, vaccination remains effective against clinical disease caused by influenza A(H3N2) viruses.

Authors

Institutions

Publication Details

Journal
Eurosurveillance
Published
2025-11-20
DOI
https://doi.org/10.2807/1560-7917.es.2025.30.46.2500854
Citations
32
Primary Topic
Influenza Virus Research Studies
Type
article
Field-Weighted Citation Impact
43.33
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early influenza virus characterisation and vaccine effectiveness in England in autumn 2025, a period dominated by influenza A(H3N2) subclade K

Heather Whitaker, Tiina Talts, Nicora Gardner, Alex Allen et al.
32 citations
Eurosurveillance
Influenza Virus Research Studies
43.33
article

Early influenza virus characterisation and vaccine effectiveness in England in autumn 2025, a period dominated by influenza A(H3N2) subclade K

Heather Whitaker, Tiina Talts, Nicora Gardner, Alex Allen, Anika Singanayagam, Katja Höschler, Conall H. Watson, Jamie Lopez Bernal, Nurin Iwani Binti Abdul Aziz, Christopher Rawlinson, Maria Zambon, Beatrix Kele, Mary Ramsay, Rebecca E Green, Catherine Quinot, Nick Andrews, E. F. Waller, Freja Kirsebom, Sarah E. McDonald, Richard Pebody, Catherine Thompson
article en
32 citations

Abstract

Influenza A(H3N2) subclade K (J.2.4.1) has dominated the 2025/26 season start in England. Post-infection ferret antisera raised against northern hemisphere 2025/26 vaccine strains showed reduced reactivity to subclade K viruses in England, aligning with World Health Organization reports. Nevertheless, early post-vaccination, vaccine effectiveness against influenza-related emergency department attendances and hospital admissions remained within typical ranges, at 72-75% in children and adolescents (< 18 years) and 32-39% in adults. Hence, vaccination remains effective against clinical disease caused by influenza A(H3N2) viruses.

EurosurveillanceVol. 30(46)
National Security Agency (US), Public Health England (GB), London School of Hygiene & Tropical Medicine (GB), NIHR Imperial Biomedical Research Centre (GB), Public Health Agency (GB), Imperial College London (GB)
Openalex Percentile: Top 0%
Influenza Virus Research Studies
43.33
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.